Patents by Inventor Su-Ya HSU

Su-Ya HSU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified chemokine peptide and use thereof
    Patent number: 12329804
    Abstract: The present invention provides a novel modified chemokine peptide. Additionally, the novel modified chemokine peptide can be used to treat cancer and inhibit tumor growth more effectively.
    Type: Grant
    Filed: August 28, 2020
    Date of Patent: June 17, 2025
    Assignee: RISE BIOPHARMACEUTICALS INC.
    Inventors: Jya-Wei Cheng, Hsi-Tsung Cheng, Hui-Yuan Yu, Su-Ya Hsu
  • Pharmaceutical compositions and use thereof for relieving anticancer drug resistance and enhancing sensitivity of anticancer drug
    Patent number: 12226454
    Abstract: The present invention provides a novel modified chemokine peptide. The novel modified chemokine peptide can be combined with a targeted drug for treating cancer, especially for treating drug-resistant cancer, and inhibiting tumor growth more effectively.
    Type: Grant
    Filed: October 30, 2020
    Date of Patent: February 18, 2025
    Assignee: RISE BIOPHARMACEUTICALS INC.
    Inventors: Jya-Wei Cheng, Hsi-Tsung Cheng, Hui-Yuan Yu, Su-Ya Hsu
  • PHARMACEUTICAL COMPOSITIONS AND USE THEREOF FOR RELIEVING RESISTANCE DUE TO CANCER CHEMOTHERAPY AND ENHANCING EFFECT OF CANCER CHEMOTHERAPY
    Publication number: 20210128683
    Abstract: The present invention provides a novel chemokine receptor antagonistic modified peptide. The novel chemokine receptor antagonistic modified peptide can be combined with a chemotherapeutic drug for treating cancer, especially for treating drug-resistant cancer, and inhibiting tumor growth more effectively.
    Type: Application
    Filed: January 8, 2021
    Publication date: May 6, 2021
    Inventors: Jya-Wei CHENG, Hsi-Tsung CHENG, Hui-Yuan YU, Su-Ya HSU, Wei-Chen LEE
  • PHARMACEUTICAL COMPOSITIONS AND USE THEREOF FOR RELIEVING ANTICANCER DRUG RESISTANCE AND ENHANCING SENSITIVITY OF ANTICANCER DRUG
    Publication number: 20210060130
    Abstract: The present invention provides a novel modified chemokine peptide. The novel modified chemokine peptide can be combined with a targeted drug for treating cancer, especially for treating drug-resistant cancer, and inhibiting tumor growth more effectively.
    Type: Application
    Filed: October 30, 2020
    Publication date: March 4, 2021
    Inventors: Jya-Wei CHENG, Hsi-Tsung CHENG, Hui-Yuan YU, Su-Ya HSU
  • MODIFIED CHEMOKINE PEPTIDE AND USE THEREOF
    Publication number: 20210046158
    Abstract: The present invention provides a novel modified chemokine peptide. Additionally, the novel modified chemokine peptide can be used to treat cancer and inhibit tumor growth more effectively.
    Type: Application
    Filed: August 28, 2020
    Publication date: February 18, 2021
    Inventors: Jya-Wei CHENG, Hsi-Tsung CHENG, Hui-Yuan YU, Su-Ya HSU